UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Dotted Core–Shell Nanoparticles for T1-Weighted MRI of Tumors Journal article
Advanced Materials, 2018,Volume: 30,Issue: 33
Authors:  Shen Z.;  Song J.;  Zhou Z.;  Yung B.C.;  Aronova M.A.;  Li Y.;  Dai Y.;  Fan W.;  Liu Y.;  Li Z.;  Ruan H.;  Leapman R.D.;  Lin L.;  Niu G.;  Chen X.;  Wu A.
Favorite  |  View/Download:12/0  |  Submit date:2019/01/15
Contrast Agents  Dotted Core–shell Nanoparticles  Longitudinal Relaxivity (R1)  Magnetic Resonance Imaging  Transverse Relaxivity (R2)  
Activatable Semiconducting Theranostics: Simultaneous Generation and Ratiometric Photoacoustic Imaging of Reactive Oxygen Species In Vivo Journal article
Advanced Materials, 2018,Volume: 30,Issue: 23
Authors:  Yang Z.;  Dai Y.;  Yin C.;  Fan Q.;  Zhang W.;  Song J.;  Yu G.;  Tang W.;  Fan W.;  Yung B.C.;  Li J.;  Li X.;  Li X.;  Tang Y.;  Huang W.;  Song J.;  Chen X.
Favorite  |  View/Download:18/0  |  Submit date:2019/01/15
Cisplatin  Ratiometric Photoacoustic Imaging  Ros Generation  Synergistic Cancer Therapy  Theranostics  
Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles Journal article
Advanced Materials, 2018,Volume: 30,Issue: 8
Authors:  Dai Y.;  Yang Z.;  Cheng S.;  Wang Z.;  Zhang R.;  Zhu G.;  Wang Z.;  Yung B.C.;  Tian R.;  Jacobson O.;  Xu C.;  Ni Q.;  Song J.;  Sun X.;  Niu G.;  Chen X.
Favorite  |  View/Download:13/0  |  Submit date:2019/01/15
Combination Therapy  Metal-polyphenol Networks  Positron Emission Tomography  Reactive Oxygen Species  Self-assembly  
Hypochlorous Acid Promoted Platinum Drug Chemotherapy by Myeloperoxidase-Encapsulated Therapeutic Metal Phenolic Nanoparticles Journal article
ACS Nano, 2018,Volume: 12,Issue: 1,Page: 455-463
Authors:  Dai Y.;  Cheng S.;  Wang Z.;  Zhang R.;  Yang Z.;  Wang J.;  Yung B.C.;  Wang Z.;  Jacobson O.;  Xu C.;  Ni Q.;  Yu G.;  Zhou Z.;  Chen X.
Favorite  |  View/Download:8/0  |  Submit date:2019/01/15
Cisplatin  Hypochlorous Acid (Hocl)  Metal-polyphenol Networks  Myeloperoxidase (Mpo)  Positron Emission Tomography  
Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy Journal article
Nanoscale, 2018,Volume: 10,Issue: 3,Page: 1135-1144
Authors:  Wang Z.;  Dai Y.;  Wang Z.;  Jacobson O.;  Zhang F.;  Yung B.C.;  Zhang P.;  Gao H.;  Niu G.;  Liu G.;  Chen X.
Favorite  |  View/Download:9/0  |  Submit date:2019/01/15
A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy Journal article
Theranostics, 2018,Volume: 8,Issue: 7,Page: 2018-2030
Authors:  Shan L.;  Zhuo X.;  Zhang F.;  Dai Y.;  Zhu G.;  Yung B.C.;  Fan W.;  Zhai K.;  Jacobson O.;  Kiesewetter D.O.;  Ma Y.;  Gao G.;  Chen X.
Favorite  |  View/Download:8/0  |  Submit date:2019/01/15
Circulation Half-life  Evans Blue  Paclitaxel Prodrug  Tumor Therapy  
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview Journal article
British Journal of Pharmacology, 2017,Volume: 174,Page: S1-S16
Authors:  Alexander S.P.H.;  Kelly E.;  Marrion N.V.;  Peters J.A.;  Faccenda E.;  Harding S.D.;  Pawson A.J.;  Sharman J.L.;  Southan C.;  Buneman O.P.;  Cidlowski J.A.;  Christopoulos A.;  Davenport A.P.;  Fabbro D.;  Spedding M.;  Striessnig J.;  Davies J.A.;  Abbracchio M.-P.;  Aldrich R.;  Al-Hosaini K.;  Arumugam T.V.;  Attali B.;  Back M.;  Barnes N.M.;  Bathgate R.;  Beart P.M.;  Becirovic E.;  Bettler B.;  Biel M.;  Birdsall N.J.;  Blaho V.;  Boison D.;  Brauner-osborne H.;  Broer S.;  Bryant C.;  Burnstock G.;  Calo G.;  Catterall W.A.;  Ceruti S.;  Chan S.L.;  Chandy K.G.;  Chazot P.;  Chiang N.;  Chun J.J.;  Chung J.-J.;  Clapham D.E.;  Clapp L.;  Connor M.A.;  Cox H.M.;  Davies P.;  Dawson P.A.;  Decaen P.;  Dent G.;  Doherty P.;  Douglas S.D.;  Dubocovich M.L.;  Fong T.M.;  Fowler C.J.;  Frantz A.;  Fuller P.;  Fumagalli M.;  Futerman A.H.;  Gainetdinov R.R.;  Gershengorn M.A.;  Goldin A.;  Goldstein S.A.N.;  Goudet C.;  Gregory K.;  Grissmer S.;  Gundlach A.L.;  Hagenbuch B.;  Hamann J.;  Hammond J.R.;  Hancox J.C.;  Hanson J.;  Hanukoglu I.;  Hay D.L.;  Hobbs A.J.;  Hollenberg A.N.;  Holliday N.D.;  Hoyer D.;  Ijzerman A.P.;  Inui K.I.;  Irving A.J.;  Ishii S.;  Jacobson K.A.;  Jan L.Y.;  Jarvis M.F.;  Jensen R.;  Jockers R.;  Kaczmarek L.K.;  Kanai Y.;  Karnik S.;  Kellenberger S.;  Kemp S.;  Kennedy C.;  Kerr I.D.;  Kihara Y.;  Kukkonen J.;  Larhammar D.;  Leach K.;  Lecca D.;  Leeman S.;  Leprince J.;  Lolait S.J.;  Macewan D.;  Maguire J.J.;  Marshall F.;  Mazella J.;  Mcardle C.A.;  Michel M.C.;  Miller L.J.;  Mitolo V.;  Mizuno H.;  Monk P.N.;  Mouillac B.;  Murphy P.M.;  Nahon J.-L.;  Nerbonne J.;  Nichols C.G.;  Norel X.;  Offermanns S.;  Palmer L.G.;  Panaro M.A.;  Papapetropoulos A.;  Perez-reyes E.;  Pertwee R.G.;  Pintor S.;  Pisegna J.R.;  Plant L.D.;  Poyner D.R.;  Prossnitz E.R.;  Pyne S.;  Ramachandran R.;  Ren D.;  Rondard P.;  Ruzza C.;  Sackin H.;  Sanger G.;  Sanguinetti M.C.;  Schild L.;  Schioth H.;  Schulte G.;  Schulz S.;  Segaloff D.L.;  Serhan C.N.;  Singh K.D.;  Slesinger P.A.;  Snutch T.P.;  Sobey C.G.;  Stewart G.;  Stoddart L.A.;  Summers R.J.;  Szabo C.;  Thwaites D.;  Toll L.;  Trimmer J.S.;  Tucker S.;  Vaudry H.;  Verri T.;  Vilargada J.-P.;  Waldman S.A.;  Ward D.T.;  Waxman S.G.;  Wei A.D.;  Willars G.B.;  Wong S.S.;  Woodruff T.M.;  Wulff H.;  Ye R.D.;  Yung Y.;  Zajac J.-M.
Favorite  |  View/Download:19/0  |  Submit date:2018/11/07
Rational Design of Branched Nanoporous Gold Nanoshells with Enhanced Physico-Optical Properties for Optical Imaging and Cancer Therapy Journal article
ACS Nano, 2017,Volume: 11,Issue: 6,Page: 6102-6113
Authors:  Song J.;  Yang X.;  Yang Z.;  Lin L.;  Liu Y.;  Zhou Z.;  Shen Z.;  Yu G.;  Dai Y.;  Jacobson O.;  Munasinghe J.;  Yung B.;  Teng G.-J.;  Chen X.
Favorite  |  View/Download:8/0  |  Submit date:2019/01/15
Amphiphilic Polymer  Cancer Therapy  Photoacoustic Imaging  Positron Emission Tomography  Redox-active Polymer  Surface-enhanced Raman Scattering  
Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture Journal article
Neurochemistry International, 2009,Volume: 55,Issue: 6,Page: 414-422
Authors:  Chan W.-S.;  Durairajan S.S.K.;  Lu J.-H.;  Wang Y.;  Xie L.-X.;  Kum W.-F.;  Koo I.;  Yung K.K.L.;  Li M.
Favorite  |  View/Download:11/0  |  Submit date:2019/01/15
6-Hydroxydopamine  Astragaloside IV  Nigral primary cell cultures  Nitric oxide synthase  Parkinson's disease  Tyrosine hydroxylase